Damià Tormo
researcher
Damià Tormo is a researcher who was instrumental in the discovery of BO-110, a synthetic RNA molecule that induces cancer cells to self-digest. He co-founded Bioncotech Therapeutics, the first company to emerge from the CNIO, which focuses on developing innovative cancer therapies.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
34,866
Power
1,044$
Sentiment
8.00
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Spain | 1 | 8.00 | 0.07% | +0% | 46,754,778 | 34,866 | $1,400,000 | 1,044$ |
| Totals | 1 | 46,754,778 | 34,866 | $1,400,000 | 1,044$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Spain:
Damià Tormo is a postdoctoral researcher who discovered a key compound for cancer treatment.
8
Juana Santiago
Marisol Soengas
Marisol Quintero
Javier Garcia Cogorro
Pedro Sanchez Perez Castejon
Tasuku Honjo
Ivan Marquez
Ilyas Sahin
El País: La odisea de tres mujeres y el BO-112, la molécula que engaña al cáncer | Ciencia